Skip to main content

Table 5 Serum amikacin concentrations (n = 26)

From: The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases

 Serum amikacin concentrations (μg/mL)

n (%)

(A) Serum amikacin concentrations just before the start of amikacin inhalation (trough concentrations)

  < 0.8

24 (92.3)

  0.8 to <1.2

2 (7.7)

  ≥ 1.2

0 (0)

(B) Serum amikacin concentrations 1 h after the start of amikacin inhalation

  < 0.8

4 (15.4)

  0.8 to <1.2

6 (23.1)

  1.2 to <1.6

8 (30.8)

  1.6 to <2.0

3 (11.5)

  2.0 to <2.4

2 (7.7)

  ≥ 2.4

3 (11.5)